IGFBP5 and breast cancer: Palpable mammary tumors were observed in female transgenic mice starting at 4 months of age, with an average of 8.4 months (Fig 4C and D), and were confirmed to have low expression of IGFBP‐5 and increased phosphorylated Akt (Fig 4D).